What is the latest SAILIFE stock price?
The latest stored price for SAILIFE is Rs 1,800.20 as of 2026-11-16.
SAI LIFE SCIENCES LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available SAILIFE price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for SAILIFE is Rs 1,800.20 as of 2026-11-16.
SAILIFE is above 50DMA, above 200DMA. The latest 50DMA is 1,570.15 and the latest 200DMA is 1,238.77.
SAILIFE has PE 101.50, ROE +16.23%, and ROCE +20.51% in Gimli's latest available snapshot.
SAILIFE has returned +29.57% over 1 month, +24.16% over 3 months, and +106.46% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 658.59 cr | 190.35 cr | 98.32 cr | 4.63 |
| 2026-06-30 | 550.27 cr | 143.45 cr | 71.34 cr | 3.46 |
| 2026-03-31 | 602.14 cr | 192.36 cr | 104.24 cr | 4.93 |
| 2025-12-31 | 556.46 cr | 187.94 cr | 100.38 cr | 4.77 |
| 2025-09-30 | 552.80 cr | 161.15 cr | 83.84 cr | 3.93 |
| 2025-06-30 | 496.42 cr | 130.84 cr | 60.45 cr | 2.90 |
| 2025-03-31 | 579.51 cr | 167.17 cr | 88.27 cr | 4.24 |
| 2024-12-31 | 439.78 cr | 128.87 cr | 53.85 cr | 2.89 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 2,192.49 cr | 672.29 cr | 348.91 cr | 16.63 |
| 2025-03-31 | 1,694.57 cr | 442.44 cr | 170.13 cr | 8.83 |
| 2024-03-31 | 1,456.47 cr | 314.58 cr | 82.81 cr | 4.43 |
| 2023-03-31 | 1,196.95 cr | 192.90 cr | 9.99 cr | 0.48 |
| 2022-03-31 | 869.17 cr | 149.43 cr | 15.68 cr | 8.82 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 3,626.14 cr | 81.91 cr | 288.45 cr | 2,483.69 cr |
| 2025-03-31 | 3,159.97 cr | 91.12 cr | 352.38 cr | 2,128.36 cr |
| 2024-03-31 | 2,275.14 cr | 23.66 cr | 927.66 cr | 975.14 cr |
| 2023-03-31 | 2,186.65 cr | 69.91 cr | 932.38 cr | 888.09 cr |
| 2022-03-31 | 2,164.23 cr | 115.94 cr | 965.45 cr | 878.57 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 509.13 cr | -83.83 cr | n/a |
| 2025-03-31 | 314.05 cr | -55.23 cr | n/a |
| 2024-03-31 | 263.09 cr | 81.40 cr | n/a |
| 2023-03-31 | 219.40 cr | 106.33 cr | n/a |
| 2022-03-31 | 104.87 cr | -102.05 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +34.50% | +19.91% | +32.32% | +29.56% | +13.26% | +0.00% |
| 2026-06-30 | +34.53% | +19.65% | +32.71% | +29.47% | +13.11% | +0.00% |
| 2026-03-31 | +34.61% | +21.17% | +31.54% | +27.80% | +12.68% | +0.00% |
| 2025-12-31 | +34.70% | +21.40% | +31.41% | +27.57% | +12.49% | +0.00% |
| 2025-09-30 | +34.94% | +22.50% | +29.91% | +26.17% | +12.65% | +0.00% |
| 2025-06-30 | +35.15% | +14.58% | +21.64% | +18.73% | +28.64% | +0.01% |
| 2025-03-31 | +35.17% | +12.36% | +13.26% | +11.54% | +39.21% | +2.67% |
| 2024-12-31 | +35.24% | +11.72% | +11.95% | +10.19% | +41.09% | +2.67% |
| 2024-12-16 | +35.24% | +7.64% | +5.61% | +4.24% | +51.52% | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.